Valuation: PharmaEssentia Corporation

Market Cap 544B 16.9B 14.77B 13.63B 12.53B 23.74B 1,626B 24.14B 163B 63.84B 795B 63.46B 62.07B 2,739B P/E 2026 *
50.7x
P/E 2027 * 36.9x
Enterprise Value 518B 16.07B 14.05B 12.96B 11.92B 22.58B 1,547B 22.97B 155B 60.73B 756B 60.37B 59.05B 2,606B EV / Sales 2026 *
20.6x
EV / Sales 2027 * 14.7x
Free-Float
75.37%
Yield 2026 *
0.07%
Yield 2027 * 0.11%
1 day+10.00%
1 week-4.30%
Current month+9.27%
1 month+53.81%
3 months+125.27%
6 months+174.20%
Current year+211.54%
1 week 1,165
Extreme 1165
1,320
1 month 887.06
Extreme 887.0636
1,415.34
Current year 423.7
Extreme 423.6991
1,415.34
1 year 395.61
Extreme 395.6133
1,415.34
3 years 222.58
Extreme 222.5833
1,415.34
5 years 56.05
Extreme 56.052
1,415.34
10 years 43.54
Extreme 43.5418
1,415.34
Manager TitleAgeSince
Chief Executive Officer - 01/01/2003
Director of Finance/CFO - 14/10/2015
Chief Tech/Sci/R&D Officer - 01/08/2022
Director TitleAgeSince
Director/Board Member 78 01/03/2014
Director/Board Member 73 01/05/2024
Director/Board Member - 30/06/2006
Change 5-day change 1-year change 3-year change Capi.($)
+10.00%-4.30%+208.33%+370.99% 16.9B
+3.13%+13.95%+64.21%+94.35% 57.82B
-1.39%-6.15%+56.05%+124.73% 53.71B
-0.27%-5.77%+6.75%+433.06% 23.8B
+1.76%-1.65%-16.86%-15.01% 23.26B
-1.11%+5.50%+43.75%-4.28% 20.7B
+1.94%+0.21%+39.31%-27.77% 17.81B
-3.36%+8.84%+45.47%+691.12% 16.36B
-0.39%-1.00%+26.08%+186.49% 13.96B
+2.49%-2.68%+76.85%+143.72% 12.69B
Average +1.25%+1.01%+54.99%+199.74% 25.7B
Weighted average by Cap. +1.12%+1.15%+53.31%+169.38%

Financials

2026 *2027 *
Net sales 25.07B 778M 681M 628M 577M 1.09B 74.91B 1.11B 7.5B 2.94B 36.61B 2.92B 2.86B 126B 34.57B 1.07B 939M 866M 796M 1.51B 103B 1.53B 10.34B 4.06B 50.48B 4.03B 3.94B 174B
Net income 10.85B 337M 295M 272M 250M 474M 32.43B 482M 3.25B 1.27B 15.85B 1.27B 1.24B 54.64B 14.97B 465M 406M 375M 345M 653M 44.74B 664M 4.48B 1.76B 21.87B 1.75B 1.71B 75.37B
Net Debt -26.52B -824M -720M -664M -611M -1.16B -79.26B -1.18B -7.93B -3.11B -38.74B -3.09B -3.03B -134B -34.73B -1.08B -943M -870M -800M -1.52B -104B -1.54B -10.38B -4.07B -50.72B -4.05B -3.96B -175B
Logo PharmaEssentia Corporation
PharmaEssentia Corp is a Taiwan-based company mainly engaged in the research, development, production and sale of new drugs. The Company is engaged in the research and development of new drugs, which are used for treatment of hematology, such as meloproliferative neoplasms (MPN), neutropenia, anemia; infectious disease, such as hepatitis C and hepatitis B; dermatology, such as psoriasis, and neurology, such as multiple sclerosis, among others. The Company’s products include KX01, P1101, Polycythemia Vera (PV), PEG-GCSF, PEG-EPO and others. The Company distributes its products within domestic market and to overseas markets.
Employees
131
Date Price Change Volume
15/07/26 NT$1,320.00 +10.00% 2,157,754
14/07/26 NT$1,200.00 -4.00% 4,037,292
13/07/26 NT$1,250.00 -2.72% 3,373,173
09/07/26 NT$1,285.00 -6.84% 6,711,957
08/07/26 NT$1,379.28 +2.34% 4,771,223
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
1,320.00TWD
Average target price
1,057.48TWD
Spread / Average Target
-19.89%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6446 Stock